Great flowchart explaining the latest guidelines on how to address residual risk beyond LDL.

On statins, high ApoB with normal LDL-C raised MI risk 49%; high LDL-C alone did not
In Copenhagen General Population Study participants on statins (n=13,015, median 8 years), high apoB with normal LDL-C had 49% higher MI rate and 21% higher mortality. High LDL-C with normal apoB showed no excess risk; non-HDL-C behaved like apoB.

